Header cover image

Chinese (SSE) Healthcare Services Industry Analysis

UpdatedMar 21, 2023
DataAggregated Company Financials
Companies39
  • 7D-3.1%
  • 3M6.0%
  • 1Y4.7%
  • YTD1.1%

The Healthcare Services is pretty flat in the last 7 days, but Shanghai Pharmaceuticals Holding has stood out, gaining 6.8%. As for the the longer term, the industry is up 10% over the past 12 months. Looking forward, earnings are forecast to grow by 31% annually.

Industry Valuation and Performance

Has the Chinese Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 21 Mar 2023CN„813.9bCN„907.3bCN„26.8b30.3x30.4x0.9x
Thu, 16 Feb 2023CN„862.8bCN„906.0bCN„26.4b32x32.7x1x
Sat, 14 Jan 2023CN„851.5bCN„905.7bCN„26.4b30.2x32.3x0.9x
Mon, 12 Dec 2022CN„799.1bCN„905.7bCN„26.4b30.1x30.3x0.9x
Wed, 09 Nov 2022CN„745.7bCN„905.7bCN„26.4b30.9x28.3x0.8x
Fri, 07 Oct 2022CN„655.4bCN„842.5bCN„23.8b21x27.5x0.8x
Sun, 04 Sep 2022CN„680.3bCN„842.5bCN„23.8b25.5x28.6x0.8x
Tue, 02 Aug 2022CN„744.0bCN„840.8bCN„24.0b32x31x0.9x
Thu, 30 Jun 2022CN„737.0bCN„839.0bCN„23.9b26.8x30.8x0.9x
Sat, 28 May 2022CN„655.1bCN„839.0bCN„23.9b25.4x27.4x0.8x
Mon, 25 Apr 2022CN„648.7bCN„821.5bCN„27.6b23.9x23.5x0.8x
Wed, 23 Mar 2022CN„647.2bCN„810.3bCN„26.5b29.1x24.4x0.8x
Fri, 18 Feb 2022CN„660.8bCN„806.8bCN„26.8b27.7x24.7x0.8x
Sun, 16 Jan 2022CN„721.1bCN„805.6bCN„26.7b27.4x27x0.9x
Tue, 14 Dec 2021CN„755.0bCN„804.6bCN„26.6b24x28.4x0.9x
Thu, 11 Nov 2021CN„748.1bCN„802.0bCN„26.5b23.3x28.2x0.9x
Sat, 09 Oct 2021CN„805.1bCN„793.2bCN„27.2b24.1x29.6x1x
Mon, 06 Sep 2021CN„745.0bCN„791.7bCN„27.1b24.6x27.5x0.9x
Wed, 04 Aug 2021CN„885.7bCN„791.5bCN„27.0b26.9x32.8x1.1x
Sat, 08 May 2021CN„939.3bCN„756.8bCN„25.2b28.4x37.3x1.2x
Tue, 09 Feb 2021CN„883.8bCN„717.0bCN„19.4b24.1x45.6x1.2x
Mon, 02 Nov 2020CN„809.1bCN„694.4bCN„13.8b20.1x58.7x1.2x
Thu, 06 Aug 2020CN„749.6bCN„677.7bCN„12.0b23.5x62.6x1.1x
Sun, 10 May 2020CN„554.1bCN„684.8bCN„9.0b17.4x61.7x0.8x
Price to Earnings Ratio

58.6x


Total Market Cap: CN„526.1bTotal Earnings: CN„9.0bTotal Revenue: CN„684.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Services Industry Price to Earnings3Y Average 38.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Chinese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.1x which is lower than its 3-year average PE of 38.8x.
  • The industry is trading close to its 3-year average PS ratio of 0.98x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 44% per year over the last three years.
  • Revenues for these companies have grown 9.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare industry?

CN Market-1.65%
Healthcare-3.57%
Healthcare Services-3.10%
Managed Healthcare0%
Healthcare Distributors-1.89%
Healthcare Services-3.91%
Healthcare Facilities-4.02%
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 194x.
    • Analysts are expecting annual earnings growth of 35.3%, which is higher than its past year's earnings growth of 19.4% per year.
  • Investors are most pessimistic about the Healthcare Distributors industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 17.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 45% over the next 5 years.
  • This is better than its past earnings decline of 6.4% per year.
  • In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
28 China National Accord MedicinesCN„45.709.1%
+CN„1.6b
38.6%PE13.2x
603882 Guangzhou Kingmed Diagnostics GroupCN„81.793.6%
+CN„1.3b
9.0%PE12.8x
300244 Dian Diagnostics GroupLtdCN„26.354.3%
+CN„677.0m
-5.1%PE7x
601607 Shanghai Pharmaceuticals HoldingCN„20.450.5%
+CN„369.8m
-18.0%PE13.9x
950 C.Q. Pharmaceutical HoldingCN„5.623.9%
+CN„366.1m
-11.9%PE8.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

28

CN„45.70

China National Accord Medicines

7D

9.1%

1Y

38.6%

600998

CN„14.96

Jointown Pharmaceutical Group

7D

0.8%

1Y

9.2%

600211

CN„53.16

Tibet Rhodiola Pharmaceutical Holding

7D

-7.8%

1Y

31.1%

603368

CN„23.85

Guangxi LiuYao Group

7D

3.2%

1Y

24.0%

300244

CN„26.35

Dian Diagnostics GroupLtd

7D

4.3%

1Y

-5.1%

963

CN„44.70

Huadong Medicine

7D

-2.2%

1Y

35.7%

301267

CN„75.44

Huaxia Eye Hospital GroupLtd

7D

-6.9%

1Y

n/a

300015

CN„30.82

Aier Eye Hospital Group

7D

-0.2%

1Y

42.8%

603882

CN„81.79

Guangzhou Kingmed Diagnostics Group

7D

3.6%

1Y

9.0%

601607

CN„20.45

Shanghai Pharmaceuticals Holding

7D

0.5%

1Y

-18.0%

600763

CN„134.56

Topchoice Medical

7D

-2.9%

1Y

6.4%

600511

CN„34.08

China National Medicines

7D

0.8%

1Y

22.3%

516

CN„10.55

Xi'an International Medical Investment

7D

-9.4%

1Y

32.7%

150

CN„1.04

Yihua Healthcare

7D

-4.6%

1Y

-67.8%